Back to Annual Meeting

Back to Annual Meeting

Abstract #160198

Rafael Guerrero-Preston, Dr PH, MPH¹, Christina Chan, MPH², David Vlahov, PhD², Maria K. Mitchell, PhD³, Stephen B. Johnson, MD⁴, and Harold Freeman, MD⁵. (1) Mailman School of Public Health, Columbia University, 722 W 168th Street, 7th floor, Department of Epidemiology and Department of Environmental Health Sciences, New York, NY 10032, 212-342-4549, reg26@columbia.edu, (2) Center for Urban Epidemiologic Studies, New York Academy of Medicine, 1216 Fifth Avenue, New York, NY 10029, (3) AMDeC Foundation, 10 Rockefeller Plaza, Suite 1120, New York, NY 10020, (4) Biomedical Informatics, Columbia University, 622 West 168th street, Vanderbilt Clinic, 5th floor, New York, NY 10032, (5) Ralph Lauren Center for Cancer Care and Prevention, 1919 Madison Avenue, New York, NY 10035

Background: Colon cancer screening rates in women are low. Whether screening for breast and cervical cancer is associated with colon cancer screening behavior is unknown but could provide linkage opportunities. Objectives: To identify the extent to which both breast and cervical cancer screening increases uptake of colon cancer screening among women in New York City. Methods: Women at least 50 years old completed questionnaires for the New York Cancer Project. Analyses compared rates of endoscopic colon cancer screening with adherence to screening recommendations for the other two procedures. Results: Of the 3,386 women, 87.8% adhered to the other two procedures, yet only 42.1% had received endoscopic colon cancer screening. Most women with colon cancer screening (95%) also reported past mammogram and Pap-smear. In multivariable analysis, women who adhered to the other two procedures were more likely to have had colon cancer screening than women with no prior history (OR = 4.4; CI = 2.36, 8.20), after accounting for age, race/ethnicity, insurance status, family history of cancer and income. Significant predictors of endoscopic colon cancer screening included: age over 65 years (OR = 1.63; CI = 1.23, 2.15) with 50-65 years old as the reference, any health insurance (OR = 2.18; CI = 1.52, 3.13) and a family history of cancer (OR = 1.38; CI = 1.17, 1.61). Conclusions: Endoscopic colon cancer screening remains low, even among those who undergo other screening tests. The opportunity to link screening tests to encourage increased uptake of colon cancer screening merits closer attention.

Learning Objectives:

• List recommended cancer screening guidelines for women aged 50 and over 2)Articulate the different colon cancer screening strategies available for people aged 50 and over 3)Discuss the predictors of colon cancer screening behavior among urban women aged 50 and over

Keywords: Cancer Screening, Women's Health

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.